Ayr Wellness Inc.
Ayr Wellness Inc. (AYR-A.CN) Financial Performance & Income Statement Overview
Review Ayr Wellness Inc. (AYR-A.CN) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Ayr Wellness Inc. (AYR-A.CN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Ayr Wellness Inc. AYR-A.CN financial performance.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $113.96M | $114.33M | $117.31M | $118.04M |
Cost of Revenue | $78.11M | $71.32M | $70.15M | $67.38M |
Gross Profit | $35.85M | $43.01M | $47.16M | $50.66M |
Gross Profit Ratio | $0.31 | $0.38 | $0.40 | $0.43 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $41.12M | $45.004M | $41.78M | $39.23M |
Operating Expenses | $169.75M | $60.46M | $54.83M | $51.31M |
Total Costs & Expenses | $247.86M | $131.77M | $124.98M | $118.68M |
Interest Income | $70000.00 | $58000.00 | $92000.00 | $103000.00 |
Interest Expense | $20.07M | $20.25M | $20.33M | $17.62M |
Depreciation & Amortization | $21.29M | $21.15M | $21.69M | $22.16M |
EBITDA | -$119.00M | $4.00M | $7.86M | $23.42M |
EBITDA Ratio | -$1.04 | $0.03 | $0.07 | $0.20 |
Operating Income | -$133.90M | -$17.44M | -$7.67M | -$1.96M |
Operating Income Ratio | -$1.18 | -$0.15 | -$0.07 | -$0.02 |
Other Income/Expenses (Net) | -$26.45M | -$19.96M | -$16.81M | -$94.89M |
Income Before Tax | -$160.36M | -$37.40M | -$24.48M | -$96.85M |
Income Before Tax Ratio | -$1.41 | -$0.33 | -$0.21 | -$0.82 |
Income Tax Expense | $3.85M | $13.11M | $14.83M | $11.48M |
Net Income | -$163.85M | -$50.63M | -$38.76M | -$106.08M |
Net Income Ratio | -$1.44 | -$0.44 | -$0.33 | -$0.90 |
EPS | -$1.44 | -$0.44 | -$0.34 | -$1.08 |
Diluted EPS | -$1.44 | -$0.44 | -$0.34 | -$1.08 |
Weighted Avg Shares Outstanding | $114.14M | $114.14M | $114.14M | $97.88M |
Weighted Avg Shares Outstanding (Diluted) | $114.14M | $114.14M | $114.14M | $97.88M |
Over the last four quarters, Ayr Wellness Inc. achieved steady financial progress, growing revenue from $118.04M in Q1 2024 to $113.96M in Q4 2024. Gross profit stayed firm with margins at 31% in Q4 2024 versus 43% in Q1 2024. Operating income totaled -$133.90M in Q4 2024, maintaining a -118% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$119.00M. Net income dropped to -$163.85M, with EPS at -$1.44. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan